Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis
埃夫加替吉莫德与静脉注射免疫球蛋白治疗即将发生重症肌无力危象患者的疗效比较
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-79918-7
Ma, Jing; Zhang, Huiqiu; Zhao, Junsen; Su, Menghan; Feng, Yingna; Yuan, Xiaoli; Liu, Dan; Pang, Xiaomin; Zhao, Rongjuan; Wang, Juan; Duan, Weisong; Chang, Xueli; Guo, Junhong; Zhang, Wei